Reduced moxifloxacin exposure in patients with tuberculosis and diabetes

Bart G.J. Dekkers; Mathieu S. Bolhuis; Lies ter Beek; Wiel C.M. de Lange; Tjip S. van der Werf; Jan-Willem C. Alffenaar; Onno W. Akkerman

doi:10.1183/13993003.00373-2019

Reduced moxifloxacin exposure in patients with tuberculosis and diabetes

Bart G.J. Dekkers, Mathieu S. Bolhuis, Lies ter Beek, Wiel C.M. de Lange, Tjip S. van der Werf, Jan-Willem C. Alffenaar, Onno W. Akkerman

European Respiratory Journal 2019; DOI: 10.1183/13993003.00373-2019

Bart G.J. Dekkers

1University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mathieu S. Bolhuis

1University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lies ter Beek

2University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands

3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wiel C.M. de Lange

2University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands

3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tjip S. van der Werf

2University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands

4University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan-Willem C. Alffenaar

1University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

5Sydney School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Onno W. Akkerman

2University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands

3University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Bolhuis has nothing to disclose.

Conflict of interest: Dr. ter Beek has nothing to disclose.

Conflict of interest: Dr. de Lange has nothing to disclose.

Conflict of interest: Dr. van der Werf has nothing to disclose.

Conflict of interest: Dr. Alffenaar has nothing to disclose.

Conflict of interest: Dr. Akkerman has nothing to disclose.

Conflict of interest: Dr. Dekkers has nothing to disclose.

This is a PDF-only article. Please click on the PDF link above to read it.

PreviousNext

View this article with LENS

Vol 59 Issue 5 Table of Contents

Table of Contents
Index by author

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Reduced moxifloxacin exposure in patients with tuberculosis and diabetes

Message Subject (Your Name) has sent you a message from European Respiratory Society

Message Body (Your Name) thought you would like to see the European Respiratory Society web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.